|REPEAT/POZEN Announces May 3, 2010 Webcast|
CHAPEL HILL, N.C., May 03, 2010 (BUSINESS WIRE) --POZEN Inc. (NASDAQ: POZN),announced today that management will hold a live webcast on May 3, 2010 at 8:30 a.m. Eastern time to discuss regulatory updates regarding VIMOVO(TM) (naproxen and esomeprazole magnesium) delayed-release tablets. The webcast can be accessed on POZEN's website at www.pozen.com and will be archived and available for replay.
POZEN Inc., headquartered in Chapel Hill, NC, is a pharmaceutical company committed to transforming medicine that transforms lives. Since its founding in 1996, POZEN has successfully created novel pharmacologic agents primarily for pain and pain-related conditions by combining existing drug therapies that result in superior patient outcomes. Moving forward, POZEN is poised to become a model 21st century pharmaceutical company dedicated to ensuring that they produce cost-effective, evidence-based medicines; take a fresh approach to sales, marketing and medical education; and deliver high-quality, affordable pharmaceuticals to their customers. The Company's common stock is traded on The NASDAQ Stock Market under the symbol "POZN". For more detailed company information, including copies of this and other press releases, please visit: www.pozen.com.
SOURCE: POZEN Inc.